Dexcom Inc. (NSDQ:DXCM) won de novo approval from the FDA for the 1st U.S. app to wirelessly connect a patient’s blood glucose monitor with up to 5 mobile devices.
Dexcom
DexCom elevates COO Sayer, Gregg to chairman | Personnel Moves
Neuromod gains CE Mark approval for tinnitus device | Regulatory news for the week of December 1, 2014
Diabetes: FDA approves Animas Vibe with DexCom’s G4 Platinum CGM
FDA approves ‘artificial pancreas’ algorithm for continuous glucose monitor | Regulatory news for the week of November 10, 2014
Diabetes: FDA OKs new ‘artificial pancreas’ software for DexCom glucose meter
Diabetes: DexCom wins FDA nod for Smart remote glucose monitor
Diabetes: Patients hack glucose monitors | MassDevice.com On Call
MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.